5:02 PM
 | 
Apr 27, 2010
 |  BC Extra  |  Company News

Protalix submits taliglucerase alfa data

Protalix Biotherapeutics Inc. (NYSE-A:PLX) submitted manufacturing validation data to FDA in response to the agency's request in February for...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >